2-Amino-1-(5-fluoropyridin-3-yl)ethanol hydrochloride, 250mg

(R)-3-Amino-3-(4-hydroxyphenyl)propanoic acid, 95.0%, 250mg

(S)-tert-Butyl 1,4-oxazepan-6-ylcarbamate, 97%, 1g

2-CHLORO-5-(TRIFLUOROMETHOXY)ISONICOTINIC ACID, 95.0%, 250mg

1,7-Dibromoheptane, 95.0%, 1g

2-((tert-Butoxycarbonyl)amino)-3-(dimethylamino)propanoic acid, 95%, 250mg

2-Hydroxy-4,6-dimethylpyrimidine, 95.0%, 25g

N-Methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide, 95.0%, 50g

[4-(Octyloxy)phenyl](phenyl)iodonium Hexafluoroantimonate>98.0%(HPLC)(qNMR)1g

2-Bromo-5-fluoro-3-methylpyridine, 97.0%, 100g

(3R,6R)-6-((R)-1,2-bis(benzyloxy)ethyl)-3-methoxy-1,4-dioxan-2-ol, 98%, 100mg

3,5-Dichloropyrazine-2-carboxamide, 95.0%, 25g

4-Bromobenzyl bromide, 98%, 5g